PCN71 Budget IMPACT Analysis of Zanubrutinib for the Treatment of Adult Patients with Mantle Cell Lymphoma WHO Have Received at Least One PRIOR Therapy from the Payer Perspective in the United States
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19553-e19553
Keyword(s):
Keyword(s):
2018 ◽
Vol 60
(4)
◽
pp. 955-963
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 53
(8)
◽
pp. 1488-1493
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. e18530-e18530
Keyword(s):
2015 ◽
Vol 15
◽
pp. S226
◽